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Abstract
Background: Gene expression profiling has the potential to unravel molecular mechanisms behind gene regulation and identify
gene targets for therapeutic interventions. As microarray technology matures, the number of microarray studies has increased,
resulting in many different datasets available for any given disease. The increase in sensitivity and reliability of measurements of
gene expression changes can be improved through a systematic integration of different microarray datasets that address the
same or similar biological questions.
Results: Traditional effect size models can not be used to integrate array data that directly compare treatment to control
samples expressed as log ratios of gene expressions. Here we extend the traditional effect size model to integrate as many array
datasets as possible. The extended effect size model (MAID) can integrate any array datatype generated with either single or
two channel arrays using either direct or indirect designs across different laboratories and platforms. The model uses two
standardized indices, the standard effect size score for experiments with two groups of data, and a new standardized index that
measures the difference in gene expression between treatment and control groups for one sample data with replicate arrays.
The statistical significance of treatment effect across studies for each gene is determined by appropriate permutation methods
depending on the type of data integrated. We apply our method to three different expression datasets from two different
laboratories generated using three different array platforms and two different experimental designs. Our results indicate that
the proposed integration model produces an increase in statistical power for identifying differentially expressed genes when
integrating data across experiments and when compared to other integration models. We also show that genes found to be
significant using our data integration method are of direct biological relevance to the three experiments integrated.
Conclusion: High-throughput genomics data provide a rich and complex source of information that could play a key role in
deciphering intricate molecular networks behind disease. Here we propose an extension of the traditional effect size model to
allow the integration of as many array experiments as possible with the aim of increasing the statistical power for identifying
differentially expressed genes.
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Background
Microarray technology is becoming an important tool for
biological research and clinical diagnostics [1], but it has
the reputation of being noisy: studies addressing the
reproducibility and reliability of microarray data across
different laboratories and platforms have resulted in
inconsistent results. Some have found agreement between
experiments [2-7] while others have not [8-11]. A study by
Irizarry et al. [12] on microarray data reproducibility has
demonstrated that disagreement observed in some of the
studies may be also due to questionable statistical analy-
sis. There is general agreement that the variability inherent
to DNA microarray technology is due to the following fac-
tors. There are a number of microarray platforms inde-
pendently developed by industry and academia. Different
protocols are used by different laboratories for RNA prep-
aration and labeling. Different statistical and computa-
tional tools are used in the analysis of the microarray
results. Due to these differences it is challenging to extract
reproducible, biologically meaningful information from
different DNA microarray experiments that address the
same, or very similar biological questions. One possible
solution to extract this information is to use meta-analysis
methods that integrate the results of separate studies in a
statistically meaningful manner. There are two main types
of meta-analysis that are commonly used for microarray
data integration. The first consists of integrating summary
measures of gene expression measurements across studies.
The advantage of this type of approach is that it avoids the
need for estimating the inter-study variability and the
issue of cross-platform normalization. Rhodes et al. [13]
were the first to implement this type of approach. This
group implemented a statistical model based on integrat-
ing p-values from individual studies to estimate the over-
all p-value for each gene across studies. The authors
integrated four published prostate cancer gene array stud-
ies. Many of the genes identified were confirmed to be
components of biologically relevant pathways, implying
that the method extracted biologically useful information.
Subsequently Parmigiani et al. [14] proposed a different
model that uses a correlation-based method to search for
consistent gene expression patterns across multiple stud-
ies. They demonstrated that their method can improve
correlation of gene expressions across studies. Rather than
combining p-values or correlations the second type of
meta-analysis consists of integrating gene expression
measures across studies. Choi et al. [15] were the first to
propose this type of approach using an effect size measure
[16] with a method that explicitly models the inter-study
variability. Using the same datasets as those used in [13],
they demonstrated that their method led to increased sen-
sitivity and reliability. Subsequently Hu et al. [17]
extended this model by incorporating a quality measure
for each gene in each study into the effect size estimates.
Using their model the authors combined two lung cancer
Affymetrix datasets generated from two different laborato-
ries and found that their method identifies more differen-
tially expressed genes than previous methods. Taken
together these studies suggest that a subset of biologically
plausible and statistically significant genes can be deter-
mined from the integration of different array technolo-
gies. With an ever-increasing amount of microarray data
being produced it is critical to develop statistically sound
methods that will efficiently integrate, evaluate and cross-
validate as many array experiments addressing the same
biological question as possible. Even though progress has
been made in integrating various array datasets, chal-
lenges still remain, one of which is that all the existing
methods require experiments with two separate groups of
data.
A two channel microarray technology continues to be
used as one of the most common platforms for gene
expression profiling [18,19]. One experimental approach
using two channel arrays is to directly compare levels of
mRNA expression between treatment and control samples
(also known as direct experimental design). Such experi-
ments lead to datasets with only one group of gene expres-
sion ratios. The method proposed in [15] can not be
applied to such datasets since it requires two groups of
data. In order to allow the integration of as many datasets
as possible, including experiments with one group of
data, we extend the model proposed in [15] and propose
a new mathematical framework for integrating microarray
experiments with one group, two groups of data or mixed
groups.
The model proposed in our study is more general than the
model proposed in [15], and allows the integration of
microarray data of any type generated across different lab-
oratories, platforms and experimental designs. As such, it
provides more flexibility for microarray data integration
than the previously published effect size based model.
The model provides also a new mathematical framework
for addressing the inter-study variation for microarray
data of different types.
Results
In order to assess the usefulness of our model to integrate
real data we applied our method to three different expres-
sion datasets generated from two different laboratories
using three different 2-channel array platforms and two
different experimental designs. All three datasets com-
pared normal liver tissue to liver tissue chronically
infected with hepatitis C virus (HCV).
Exploratory data analysis
Before data integration was carried out, an exploratory
data analysis as proposed in [20] was conducted to deter-
mine if there were any fundamental differences betweenBMC Bioinformatics 2008, 9:305 http://www.biomedcentral.com/1471-2105/9/305
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experiments that would preclude data integration. As
shown in Figure 1, low correlation coefficients were
observed between estimated effect sizes of the three stud-
ies: ,    and
. These low correlation coefficients
highlight differences between the three experiments. In
high-throughput microarray experiments, a common
expectation is that the majority of genes in each study will
show little or no difference between conditions. Figure 2
shows the distributions of z scores (see Methods section
eq.15) in the three experiments, all of which are centered
around zero. This finding indicates that most of the genes
in each experiment show little or no differences between
treatment and control samples. A significant deviation
from zero in any of the three datasets, due to some large
systematic effect, would be indicative of fundamental dif-
ferences between experiments that could not be solved by
statistical means. Thus even when low correlations
between experiments are observed (for example due to a
large number of genes having log2 expressions close to
zero with random measurement error) this does not auto-
matically imply that small sets of genes with significant
effects across experiments would not be observed and that
data integration should not be considered.
By adopting a similar approach to Kim et al. [36] we
present a cluster plot in Figure 3 that shows a relationship
between the three datasets before data integration. We
R Tv s W cDNA cDNA () .    = 01 3 R Tv s W cDNA oligo () .    = 01 4
R Wv s W oligo cDNA () .    = 03 8
Effect size correlations between experiments Figure 1
Effect size correlations between experiments. Correlation plots of effect sizes between three experiments; 1a) R = 0.13 
(Toronto-cDNA vs Washington-cDNA), 1b) R = 0.14 (Toronto-cDNA vs Washington-oligo), and 1c) R = 0.38 (Washington-
oligo vs Washington-cDNA).
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find that if clustering of individual samples is done using
relative gene expressions (i.e expressions of genes in HCV
to normal tissue), the samples cluster according to each
individual platform, indicating the presence of intra-study
variability due to lab/platform effects.
In order to test for homogeneity between datasets, we
used the Cochran Q statistics given in eq.10 (see the Meth-
ods section). The results of the test are shown in Figure 4.
The observed Q values from the three experiments deviate
significantly from the expected quantiles of the   dis-
tribution, suggesting that the three datasets are heteroge-
neous. Heterogeneity indicates significant variability
between studies that requires a random effect model
(REM) to be fitted. When applied to our pre-processed
datasets, the REM model found a set of 451 significant
genes with FDR ≤ 0.05. In order to asses the advantage of
integrating these three datasets together, we first deter-
mined the number of genes that had an FDR ≤ 0.05 in the
meta-analysis study but for which the FDR in all three
studies was higher than the FDR in the meta-analysis
study. Of the total of 451 genes in the meta-analysis study,
we found 237 to satisfy this criterion. We designated these
genes as integration-driven discovery (IDD) genes as first
introduced in [15]. Figure 5 shows a plot of the gene
number versus FDR (FDR ≤ 0.05) for each independent
dataset and demonstrates that the largest number of sig-
nificant genes is observed in the meta-analysis. This
increase in the number of significant genes is an indica-
tion of the potential benefit in integrating these three
datasets using our model.
Genes determined to be significant in the meta-analysis 
model
In order to further assess the advantage of data integra-
tion, we decided to examine whether genes found in our
analysis had direct biological relevance. Genes that are
determined to have statistically significant expression
level changes may still have low fold increases (or
decreases) that might not be biologically relevant.
Although there is no consensus in fold increase/decrease
associated with 'biological relevance', we chose a fold
change of at least 1.5 (increased or decreased) between
HCV and normal in at least one of the three integrated
studies based on the estimate of the median standard
deviation (median sd = +/- 0.23) of fold gene expression
measurements in the three experiments (a 1.5 fold cuto3
on gene expression levels is 2 standard deviations away
from the mean of genes with no expression (i.e fold = 1),
and thus is less likely to be confounded with non-
expressed genes). We found a total of 206 genes to satisfy
those criteria. Of the 206 genes, 79 genes were integration-
driven discovery (IDD) genes as defined in [15]. We have
used a 1.5 fold cutoff in our previous array studies using
clinical samples and have determined a number of biolog-
χ() l−1
2
Boxplot of effect sizes for the three experiments Figure 2
Boxplot of effect sizes for the three experiments. Boxplot showing z scores of the three experiments to be centered 
around zero indicating that the three experiments are measuring similar differences between conditions.
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ically-relevant effects (Chen et al. [31], Borozan et al. [30],
Chen et al. [37]), and were able to validate 85 % of genes
expressed at the 1.5 fold level, using quantitative real time
– PCR (for more detail about gene validation we refer the
reader to [30,31]).
Biological pathway analysis
In order to determine the biological themes overrepre-
sented in our gene list, we used the R package GOstats
[21]. GOstats searches for overrepresented GO biological
themes by determining if a given GO category contains
more genes determined to be significant in a given exper-
imental condition than one might expect by chance. Tak-
ing p-values <0.05 for significant overrepresentation we
found a number of enriched GO biological processes to be
associated with HCV infection including: immune
response, defense response and response to virus. Many of
the genes in each of the enriched GO categories (see Table
1 for the top ten GO categories (see Additional file 1, for
the full table of the GO over-represented BP categories))
have been found to play key roles in host antiviral
response to HCV infection [22], a number of which are
interferon stimulated genes (data not shown here).
In order to determine if particular biochemical pathways
were enriched in genes from our list of 206 genes, we per-
formed a KEGG pathway database [23] query using the R
package GOstats [21]. We identified five significantly
enriched KEGG pathways termed; "Antigen processing
and presentation" (p-value ≤ 8.2e-05), "Type I diabetes
mellitus" (p-value ≤ 1.3e-03), "Ribosome" (p-value ≤
3.8e-03), "Toll-like receptor signaling pathway" (p-value
≤ 4.4e-02) and "Linoleic acid metabolism" (p-value ≤
4.7e-02) using the Hypergeometric test of GOstats pack-
age (see Table 2). Three of the five enriched pathways
found in our analysis have been directly associated in pre-
vious studies with HCV. Genes from KEGG's "Antigen
processing and presentation" pathway were associated
with HCV persistence in infected individuals [24], genes
from the "Ribosomal" pathway were shown to interact
with the virus RNA internal ribosomal entry site [25-27],
Quantile-Quantile plot Figure 4
Quantile-Quantile plot. Gene by gene testing for the 
homogeneity of study effects. Overall test results are shown 
by the Quantile-Quantile plot of the observed (black curve) 
vs expected Q quantiles (red curve), the expected Q values 
are from the   distribution, where l designates the 
number of experiments. The difference between the 
observed and the expected Q quantiles are large and show 
that a random effect model should be considered for data 
integration.
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Unsupervised hierarchical clustering analysis Figure 3
Unsupervised hierarchical clustering analysis. An 
unsupervised hierarchical clustering of individual samples was 
performed using relative gene expression (i.e ratios of gene 
expressions in HCV and normal tissue). Samples cluster 
according to each individual platform, indicating the presence 
of intra-study variability due to lab/platform effects (UT des-
ignates cDNA arrays/samples from University of Toronto, 
W-cDNA designates cDNA arrays/samples from University 
of Washington, and W-oligo designates oligo arrays/samples 
from University of Washington).
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while genes from "Toll-like receptor signaling pathway"
have been shown to be modulated by HCV proteins in
liver cells [22]. These findings indicate that our model is
selecting genes that are enriching pathways relevant to
HCV infection. More importantly two of the five enriched
KEGG pathways ("Antigen processing and presentation"
and "Type I diabetes mellitus") obtained through data
integration were found not to be enriched in any of the
three individual studies, in other words these pathways
were identified purely by means of meta-analysis. They
are an example of how weak but consistent signals across
the three studies are brought together in order to achieve
more reliable results, highlighting the effectiveness of our
integrative approach. Because many of the genes found in
this study are of direct relevance to the Hepatitis C disease,
a more detailed study of biological implications of our
findings will appear in a separate paper.
Comparison of MAID with other integration methods
In this section we compare results from data integrated
with MAID to results integrated with the other methods
mentioned in the Background section. Among four pro-
posed methods for microarray data integration [13-
15,17], only two methods based on combining summary
measures (Rhodes et al. [13] and Parmigiani et al. [14])
can be applied to datasets with both one and two groups
of data (a single group of data with two-color array tech-
nology can be produced using a direct design approach
where disease and control samples are co-hybridized on
the same array). The second index introduced in our
model allows the general framework proposed in [15] to
be extended and applied to datatypes that previously
could not be integrated with this method.
In order to compare results obtained from these three dif-
ferent models we compared gene lists selected as signifi-
cant by each individual method. In order to make a valid
comparison the selected gene sets were required to have
the same expected number of false positives E(F P), in this
way the comparison between results obtained with MAID
and results obtained with other models is ensured to be
done at the same statistical significance level (see Tables 3,
4 and Figure 6). For the purpose of comparison we chose
a reasonably conservative value for E(F P) of 10 (see also
Figure 6b). The biological relevance of gene sets selected
by each individual model is then evaluated by comparing
the significance, the biological relevance and the content
(i.e gene number) of enriched GO biological process cat-
egories.
In Figure 6 we show the plot of the number of genes
selected by each individual model versus the expected
number of false positives. We found that the MAID model
Table 1: Significantly over-represented GO biological processes
GO over-represented categories GOBPID P value OddsRatio ExpCount Count Size
immune response GO:0006955 8.39E-008 3.56 11.25 31 196
organismal physiological process GO:0050874 1.35E-007 2.69 24.44 50 426
response to biotic stimulus GO:0009607 4.71E-007 3.18 12.74 32 222
defense response GO:0006952 4.76E-007 3.24 12.11 31 211
response to stimulus GO:0050896 2.75E-005 2.15 28.23 49 492
regulation of caspase activity GO:0043281 3.20E-004 22.41 0.4 4 7
response to pest, pathogen or parasite GO:0009613 1.01E-003 2.72 6.83 16 119
response to other organism GO:0051707 1.32E-003 2.64 7 16 122
physiological process GO:0007582 4.77E-003 2.2 146.25 157 2549
Shows the top ten over-represented GO biological process categories obtained from the list of genes determined to be significant using MAID 
(Micro Array Data Integration Model). The over-represented GO categories are ordered according their statistical significance in decreasing order 
(Count designates for each GO category term tested, the number of genes from the significant gene list that are associated with that term, Size 
designates the total number of genes associated with each GO term tested and ExpCount designates the expected number of genes obtained by 
chance alone for each GO term tested).
Meta-analysis false discovery rate Figure 5
Meta-analysis false discovery rate. The number of genes 
vs their significance for individual studies and for the inte-
grated study.
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selects more genes when compared to the other two mod-
els for the same expected rate of false positives (i.e E(F P)
= 10, see also Figure 6b). For the purpose of clarity Figure
6b shows the same plot as Figure 6a but limited to gene
lists with the expected number of false positives E(F P) ≤
21. The number of significant genes selected by each
model is given in Table 3.
In order to asses whether the larger gene set selected by the
MAID model (for the same expected false positive rate E(F
P) = 10) enriches relevant biological categories we com-
pared the enriched GO biological process (BP) categories
obtained from gene lists selected by each individual
model. We also imposed a threshold on selected genes'
fold changes by requiring genes to be up (or down) regu-
lated by |fold| ≥ 1.5 (for the reasons noted earlier) in HCV
samples when compared to Normals (see Table 3). In
Table 4 we give the top 5 enriched GO categories from
each model.
As shown in Table 4 enriched GO (BP) categories
obtained with a correlation-based method proposed by
Parmigiani et al. [14] are less significant than categories
obtained from either MAID or the model proposed by
Rhodes et al. [13], and contain many fewer genes (no
more than two per category) that show no clear relevance
to the HCV disease.
Of the top five significantly enriched GO (BP) categories
obtained with gene sets selected by the model proposed
by Rhodes et al. [13] and MAID, two can clearly be associ-
ated with HCV disease; these are "immune response" and
"defense response" (see Table 4). Table 4 shows that the
enrichment in genes selected by the MAID model is higher
False discovery rate for the three integration methods Figure 6
False discovery rate for the three integration methods. Figure 6a shows the plot of the number of genes selected by 
each method versus the expected number of false positives (E(F P)), figure 6b shows the same plot as figure 6a with the 
expected number of false positives E(F P) ≤ 21.
0 1000 2000 3000
0
1
0
0
0
2
0
0
0
3
0
0
0
Number of genes selected
E
x
p
e
c
t
e
d
 
n
u
m
b
e
r
 
o
f
 
f
a
l
s
e
 
p
o
s
i
t
i
v
e
s
MAID
Rhodes et al.
Parmigiani et al.
6a
0 100 200 300 400
0
5
1
0
1
5
2
0
Number of genes selected
E
x
p
e
c
t
e
d
 
n
u
m
b
e
r
 
o
f
 
f
a
l
s
e
 
p
o
s
i
t
i
v
e
s
MAID
Rhodes et al.
Parmigiani et al.
6b
Table 2: Significantly over-represented KEGG pathways
KEGG over-represented pathways P value
Antigen processing and presentation 8.16E-005
Type I diabetes mellitus 1.26E-003
Ribosome 3.76E-003
Toll-like receptor signaling pathway 4.40E-002
Linoleic acid metabolism 4.65E-002
Shows over-represented KEGG pathways obtained from the list of 
genes determined to be significant using MAID (Micro Array Data 
Integration Model).BMC Bioinformatics 2008, 9:305 http://www.biomedcentral.com/1471-2105/9/305
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for both of these categories "immune response" p-value =
4.96e-6 (MAID) vs p-value = 1.84e-5 (model from Rhodes
et al. [13]) and "defense response" p-value = 1.81e-5
(MAID) vs p-value = 3.54e-5 (model from Rhodes et al.
[13]). These results indicate that when gene sets selected
by the model from Rhodes et al. [13] are compared by
those selected by MAID, the larger MAID gene set
improves the enrichment significance of the two of the
most significant and HCV relevant GO categories and
points to an increase in statistical power when compared
to the model proposed by Rhodes et al. [13].
As shown in Figure 7 the highest overlap in genes selected
by each individual model was observed between the
MAID model and the model proposed by Rhodes et al.
[13] (23 genes) while the lowest overlap and highest dis-
crepancy in genes and GO enriched categories was
observed when comparing results obtained with either the
MAID model or the model of Rhodes et al. [13] with the
correlation-based method proposed by Parmigiani et al.
[14]. The overlap in genes between the model proposed
by Rhodes et al. [13] and the model proposed by Parmi-
giani et al. [14] and the overlap between MAID and the
model proposed by Parmigiani et al. [14] are both very
low (zero and four genes respectively).
Discussion
In this study we introduce a new effect size based model
for microarray data integration. We demonstrate that our
model, together with appropriate data pre-processing
methods, can be used to integrate expression data across
different laboratories, array platforms and experimental
designs that results in an increase in statistical power for
identifying differentially expressed genes when integrat-
ing data across experiments. Moreover, we show that
genes selected as significant by our model enrich relevant
biological pathways and processes.
Overlap of genes found to be significant by each of the three  integration methods Figure 7
Overlap of genes found to be significant by each of 
the three integration methods. Overlap among top 
genes selected from each of the three methods with E(F P) = 
10.
Rhodes et al. Parmigiani et al.
MAID 0
323
46
4
14
23
0
0
Table 3: The number of significant genes selected by each of the three integartion models with E(F P) = 10
# of genes # of genes # of genes
(Rhodes et al.) (Parmigiani et al.) (MAID)
E(FP) = 10 37 50 350
E(FP) = 10 and |fold| ≥ 1.5 37 14 159
The number of significant genes selected by each model. The first row designates the number of genes selected by each model with the expected 
rate of false positives E(F P) = 10. The second row designates the number of genes from the first row that are either up (or down) regulated in HCV 
samples compared to Normal with |fold| ≥ 1.5
Table 4: Top five over-represented GO biological process 
categories obtained with three different integartion models
GO (BP) categories P values # of genes
MAID
organismal physiological process 8.90E-007 41
immune response 4.96E-006 24
response to biotic stimulus 1.41E-005 25
defense response 1.81E-005 24
response to stimulus 1.98E-004 39
Rhodes et al.
response to biotic stimulus 8.12E-006 11
immune response 1.84E-005 10
response to pest, pathogen or parasite 2.12E-005 8
response to other organism 2.54E-005 8
defense response 3.54E-005 10
Parmigiani et al.
glyoxylate metabolism 4.44E-003 1
sphingolipid catabolism 4.44E-003 1
sphingomyelin metabolism 4.44E-003 1
sphingomyelin catabolism 4.44E-003 1
coagulation 8.37E-003 2
Top five enriched GO categories obtained with, MAID, Rhodes et al., 
and, Parmigiani et al. In each case genes had to be up (or down) 
regulated |fold| ≥ 1.5 in HCV samples compared to Normal with an 
expected number of false positives E(F P) = 10 for each gene list.BMC Bioinformatics 2008, 9:305 http://www.biomedcentral.com/1471-2105/9/305
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In order to obtain the best possible results with our
model, a number of important problems relating to each
individual data set had to be addressed. First, it is only rea-
sonable to integrate experiments that aim to address the
same or similar biological questions. In order to address
the problem of matching of samples and experiments, we
integrated only experiments that compared samples of
same biological type. Second, because most of the disa-
greement between individual array experiments was
found to be due to platform-dependent probe effects [12],
we decided to use only relative gene expression ratios
instead of absolute measurements. Third, in order to
ensure better agreement between gene annotations across
platforms, we focused only on genes that had identical
annotation entries in the NCBI Entrez Gene database.
After addressing the problem of matching of probes, sam-
ples and experimental conditions we used exploratory
analysis methods proposed in [20] to determine if data
from the three experiments presented any important sys-
tematic bias that would preclude their integration. We
found all three datasets to show low correlation coeffi-
cients between their effect sizes – though a slightly higher
correlation coefficient was found for datasets from the
Washington group (see Figure 1). However, inspection of
individual effect size distributions showed no fundamen-
tal differences between the three datasets (see Figure 2).
Low correlations of effect sizes could result from a small
group of genes showing similar effects across the three
experiments. When expression measurements were inte-
grated using the above methodology, we found 451 genes
to be significantly expressed across all three studies with a
false discovery rate (FDR) ≤ 0.05. Of these 237 had higher
statistical significance in the integrated study than in any
individual study. Of 79 integration driven discovery genes
found with absolute fold expression greater than 1.5, 57
were shown to be up-regulated (or down-regulated) by at
least 1.5 fold in only one of the three studies. This result
suggests that the magnitude of fold increase (or decrease)
in each individual experiment is a poor indicator of the
overall gene activity when comparing across experiments
and that a more suitable metric such as effect size needs to
be used. Furthermore, of the 206 genes that were found to
be significant (with fold ≥ 1.5) in our analysis, 11 were
found not to be significant in any of the individual stud-
ies. The potential involvement in HCV disease of these
genes identified through meta-analysis alone will require
further biological study. Of four previously published
methods proposed for microarray data integration [13-
15,17], two methods [13,14], based on combining sum-
mary measures, can be applied to datasets generated with
mixed groups (i.e with two groups and a single group of
data). Comparing results obtained with MAID to results
obtained with the models proposed by Rhodes et al. [13]
and Parmigiani et al. [14], we found that MAID selects
more genes than any of the summary statistics based
methods, and that additional genes selected by MAID are
relevant to the HCV disease. Genes selected by MAID pro-
duce an increase in enrichment of relevant HCV GO cate-
gories when compared to results obtained with the two
summary statistics methods (see Table 4). These findings
argue that MAID produces less conservative results that
are also biologically more relevant, indicating an increase
in statistical power.
The overlap in results of the top genes selected by each
method (for exactly the same number of expected false
positives) indicates that models based on integrating p-
values [13] and effect sizes (i.e MAID), across experi-
ments, give more similar results than the model based on
integrating gene correlations [14].
Models based on summary statistics that integrate p val-
ues [13] or expression correlations [14] across studies can
be used to obtain more precise estimates of significance of
gene expressions than those obtained from the individual
array studies (see for example [13]). However such
approaches do not take into account the inter-study vari-
ability and can produce results that are significant even for
genes that have significant fold changes but that are
observed to be expressed in opposite directions (increased
versus decreased) across studies. Models that do take the
inter-study variability into account, such as Choi et al.
[15] and MAID, would not consider such changes as sig-
nificant (for example data integration using the model
proposed by Rhodes et al. [13] leads to 19 genes that are
significant but for which the fold increase/decrease is
directed in opposite directions by at least 1.5 fold in at
least one of the studies). In addition to ignoring the direc-
tion of change in gene expressions across studies, sum-
mary-statistics based models do not take the magnitude of
observed effects (i.e fold changes) into account either. In
this way significant statistical changes (or small p values)
might not necessarily correspond to important biological
effect (i.e fold changes) and could inflate the number of
false positives. Effect size based models instead, integrate
data directly by taking into account the magnitude of the
effect and its consistency both within and across studies.
Moreover it has been shown that models based on inte-
grating summary statics are less sensitive to small but con-
sistent expression changes than an effect size based model
(see Choi et al. [15]).
Though we agree in principle with the approach proposed
in Choi et al. [15], we note that the model assumes that a
fixed or random effect model should be fitted for all the
genes. However, this approach might not always be
appropriate. As pointed out in [20], it is more likely that
for some genes there would be no effect observed, while
for others a fixed or random effect model would be moreBMC Bioinformatics 2008, 9:305 http://www.biomedcentral.com/1471-2105/9/305
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appropriate. A more flexible approach should improve
the sensitivity and reliability of this model. Furthermore,
as noted in [15], for microarray data and biological sys-
tems in general, genes can not always be assumed to act
independently, but often show dependency through inter-
actions and correlations. Without a better understanding
of gene-gene interaction structures, it is difficult to realize
how such improvements could be included in the model.
We also note that particular care needs to be taken when
integrating many small-sized microarray studies with this
model as the estimated between study variability τ2 will be
biased and would influence overall results [20,28].
The approach proposed in our study differs from that of
[15] and the GeneMeta algorithm [21] in several impor-
tant aspects. The set of methods proposed in [15], as
implemented in the GeneMeta [21] algorithm, can only
be applied to experiments with two separate groups of
data and thus can not be applied to two-channel microar-
ray experiments measuring differences in gene expression
values between treatment and control groups using a
direct experimental design. In order to integrate as many
microarray datasets from the public domain as possible
we proposed a new integration method which we imple-
mented in form of the R package MAID (we have made
every effort possible to provide an R package with an easy
to understand, high-quality documentation for non-
expert R users, the package is available upon request from
the corresponding authors and will be submitted to the
Bioconductor [21] project to ease access and dissemina-
tion).
In MAID the type of analysis applied depends on the type
of data analyzed. Thus for microarray experiments with
two groups of data we use the standard effect size model
proposed in [15]. For microarray experiments with one
group of data we propose a second standardized index
based on the paired t-statistic (see eq.6 in Methods sec-
tion) which follows a Student's t-distribution times  ,
with (n - 1) degrees of freedom (where n is the number of
microarray replicates).
In addition to eq.6 (see Methods section) we also propose
new estimators for both the pooled standard deviation
(which is now given in eq.7 and which replaces the
pooled standard deviation given in eqs.2–3 in the Choi et
al. model) and the estimated variance (which is now given
in eq.8 and which replaces the estimated variance for the
unbiased effect size given in eq.5 in the Choi et al. [15]
model).
Although we adapt the same general hierarchical model
framework as described in Choi et al. [15], a major differ-
ence is that for direct design experiments the inter-study
variability given in eq.12 (first proposed by DerSimonian
and Laird [29]) is calculated using new expressions for the
pooled standard deviation and the estimated variance
given in eq.7 and eq.8, instead of the expression given by
Choi et al. in eq.3 and eq.5 (see Methods section).
The same changes occur in eqs.9–15 with new estimators
replacing those described in Choi et al [15]. Depending
on the type of datasets integrated the homogeneity test is
calculated using either one or both types of standardized
indices and their respective variances. MAID implements
a permutation method that is specific for each data type,
experiments with two groups of data are considered as a
two class label case, while experiments with one group of
data are considered as a one class label case. In addition to
the permutation method for a two class label case, MAID
implements a second permutation method (a feature
which did not exist in the model proposed by Choi et al.)
for a single class label case necessary in the calculation of
false discovery rate (FDR) (see eq.16 in Methods section).
Without the proposed new estimators given in eqs.6–8
(see Methods section) and their implementation through
eqs.10–16 (see Methods section) it would not have been
possible to integrate array experiments with both direct
and indirect designs using a more sophisticated model,
such as the one proposed in this study that takes both the
intra and inter-study variability into account.
Conclusion
Traditional effect size models [15] are limited to integra-
tion of array datasets with two groups of data. Here we
extend the traditional effect size model in order to
increase the sample size by allowing the integration of
array experiments of any type. Using our model we have
shown that it is possible to detect small but consistent
changes in gene expression across these three biologically
similar but independent studies. Genes with weak signals
in each individual experiment can be seen as potential
false negatives. We have shown that the number of false
negatives can be decreased effectively by using our model.
We have also demonstrated that a sizable number of genes
could be cross-validated through inter-study comparison
indicating that these studies show a certain degree of
reproducibility. Our results also indicate that technical
and biological variability present in datasets obtained
from different laboratories, different platforms and
designs can be overcome by appropriate data pre-process-
ing and meta-analysis methods. By comparing our model
to other integration methods available, we show that our
model selects more genes (for the same number of
expected false positives) that are of direct biological rele-
vance to the experiments under consideration.
1
nBMC Bioinformatics 2008, 9:305 http://www.biomedcentral.com/1471-2105/9/305
Page 11 of 15
(page number not for citation purposes)
Finally we have shown that most of the genes found to
improve in significance after data integration with our
model are of direct biological relevance to the three exper-
iments. High-throughput proteomics and genomics data
provide a rich and complex source of information which
may help to decipher the complex molecular networks
behind disease. Beyond the analysis of the gene expres-
sion data presented in this study, our model provides a
way of integrating multiple microarray datasets across a
broad range of cross-platform studies, and allows a more
general and flexible framework for microarray data inte-
gration.
Methods
Data sources and preprocessing
Three microarray expression datasets from two laborato-
ries were collected. Two datasets were obtained from the
University of Washington. These datasets were collected
using two different versions of Agilent array technology.
One dataset was generated using two-channel Agilent
Human 1 cDNA array platform containing 12,814 probes.
This study used a direct design and included 13 chronic
HCV samples co-hybridized with 13 normal samples. The
second dataset was generated using two-channel Agilent
Human 1A (V2) 60-mer oligonucleotide array platform
containing 20,173 probes. This study used direct design
and included 5 chronic HCV samples co-hybridized with
5 normal samples. The third dataset was obtained from
the University of Toronto UHN Microarray Liver Disease
Project [30,31]. This dataset was generated using two-
color UHN cDNA microarray slides containing 19000
probes. This study used indirect design and included 40
chronic HCV samples co-hybridized to reference RNA and
20 normal samples co-hybridized to the same reference
RNA. In total 78 samples were collected across the three
studies. All arrays from University of Washington group
were normalized using the Rosetta Resolver error model
[32] while all arrays from University of Toronto were nor-
malized using an R-based, intensity-dependent LOWESS
scatter plot smoother (see the Methods section of [31]).
Prior to data-integration all expression data were log2
transformed.
Annotation
In order to assure the best possible match for features
across different microarray platforms, we used mappings
that matched each feature to genomic information availa-
ble from the NCBI Entrez gene database. We used the R
package AnnBuilder [21] to match probe GeneBank iden-
tifiers provided by each manufacturer to Entrez Gene
identifiers from NCBI. Only probes that had an entry for
each platform were considered for further analysis. Figure
8 is a Venn diagram demonstrating the degree of agree-
ment between each platform using Entrez Gene identifi-
ers. Only probes that have been annotated and for which
the measured intensity was available after image and data
processing in each of the three studies were considered for
further analysis. A list of 3885 genes was found to be con-
sistently annotated between the three studies (see Figure
8); of those 3770, were found to have intensity measure-
ments across all studies. The gene annotation overlap
found in our study is similar to the gene annotation over-
lap found in a cross-study comparison of three different
experiments done on different platforms (two channel
cDNA arrays and single channel Affymetrix arrays) [14].
Data integration with models proposed by Parmigiani et al. and 
Rhodes et al
We used the R package MergeMaid [21] to integrate the
three dataset using the integration model proposed by
Parmigiani et al. [14].
The integration model proposed by Rhodes et al. [13] was
implemented in R as follows. Gene specific p-values were
computed separately for each study and combined using
the Fisher summary statistics S  as shown in equation
below
where pj is the gene specific p-value for the jth study. The
summary S statistics is then compared to an empirical dis-
Sl o g p j
j
l
=−
= ∑ 2
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Gene annotation overlap between experiments Figure 8
Gene annotation overlap between experiments. Venn 
diagram showing agreement between annotations across 
three different platforms using Entrez Gene identifiers.
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tribution, obtained by computing summary statistics S
from 100000 random permutations of p-values from each
study. The meta-analysis p-value are computed as the pro-
portion of random S statistics larger than the actual S sta-
tistics. To estimate the false discovery rate we used the R
package qvalue [21,33] with the λ parameter set to zero
that produces an estimate of FDR according to the meth-
odology proposed by Benjamini and Hochberg [34].
Microarray Data Integration Model (MAID)
Effect size
Microarray experiments are done using either two-chan-
nel (e.g. custom or commercially available cDNA or oligo-
nucleotide arrays) or single channel arrays (e.g
Affymetrix). For two-channel arrays the experimenter can
chose between either direct or indirect designs. There are
several distinct steps involved in producing two-color
microarrays. In a direct design for two color cDNA micro-
arrays, treatment and control target mRNA samples are (i)
reverse-transcribed into cDNA (ii) labeled with different
fluorescent dyes (usually red-fluorescent dye, Cy5 and
green-fluorescent dye Cy3), (iii) mixed in equal propor-
tions and hybridized to DNA probes on the glass slide. In
the case of indirect design a common reference is used on
all the arrays. The basis for the model used in our analysis
was first proposed by Choi et al. [15]. A recent implemen-
tation of this model using the R package GeneMeta [21]
allows experiments with two separate groups of data to be
integrated. This model cannot be applied to two-channel
microarray experiments done using a direct design
approach in which only one group of data is available.
Limiting data integration to experiments with two sepa-
rate groups of data would be wasteful of other potentially
valuable data sets. In this study we describe a new model
implemented in form of the R package MAID (Microarray
Data Integration Model) that can integrate two-channel
array experiments with both direct and indirect designs
(the R package MAID is available from the corresponding
authors upon request). For experiments with two groups
of data we follow the implementation of the GeneMeta
[21] algorithm. For the case where only one group of data
is available we introduce a new standardized index as a
measure of the mean difference between treatment and
control samples. The model in [15] and GeneMeta [21]
use a well-known effect size estimator [16] as a standard-
ized measure of mean differences between treatment and
control groups. The expression for the effect size is given
in eq.1
where t is the usual t-statistic given in eq.2
and nt and nc are individual sample sizes for treatment and
control groups.
The estimator in eq.1 estimates the effect size based on the
difference between the average gene expression values in
the treatment and control groups (  and  ) divided
by the pooled standard deviation σ expressed in eq.3
where S1 and S2 are standard deviations of treatment and
control groups.
Hegdes and Olkin [16] have suggested correcting the
effect size given in eq.1 for the sample size bias as shown
below
where n = nt + nc.
The estimated variance σ2(d') for the unbiased effect size
is given in [16] as
For studies that measure the mean difference between
treatment and control groups using a direct design
approach we introduce a new standardized index given in
eq.6
where n is the sample size and tpaired is the the expression
for the paired t-statistic given in eq.7
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where   is the mean difference between treatments and
control for one sample data,   is the sample variance
and tpaired is the Student t quantile with (n - 1) degrees of
freedom.
Because tpaired follows a t distribution with (n - 1) degrees
of freedom, d" is distributed as   times a t-variate with
(n - 1) degrees of freedom. Thus the mean and the vari-
ance of the standardized index d" can directly be obtained
from the mean and the variance of the t-distribution as
shown in eq.8
where ν designate the number of degrees of freedom (ν =
n - 1). The null hypothesis H0 tested by tpaired is thus that of
no differences between treatments and control for one
sample data (i.e H0:μ = 0). We note that for studies with
direct design nt and nc denote the number of co-hybridized
treatment and control samples for each one of the Cy5
and Cy3 channels with nt = nc = n, where n designate the
total number of array replicates.
In our implementation the correct specification of the
class labels depends on the type of data analyzed. Thus on
the basis of class labels specified, our algorithm identifies
the two types of data automatically. Experiments using
two channel arrays with direct design correspond to the
one-class label case while experiments with two groups of
data correspond to the two class label case. Depending on
the data type given, a t-statistic is calculated using either a
two sample Welch t-statistic for the two class label case or
a paired t-statistic for a single class label case. In both cases
the  t-statistics is calculated using the mt.test-
stat.num.denum() function from the R package multtest
[21].
Hierarchical model
The hierarchical effect size model proposed by Choi et al.
[15] is given as
where yj is the observed effect size in study j, θj is the mean
gene expression in study j, μ is the average measure of dif-
ferential expression for each gene across datasets, τ2 is the
estimated between study variability and sj is the estimated
within-study variance.
Let   denotes the observed unbiased effect size in study
j for the two group data case and   denotes the observed
standardized index in study j for the one group data case.
In our implementation yj from eq.9, designate either 
(see eq.4) for the two group data case or   (see eq.6) for
the one group data case. In the same way sj is calculated
using either the expression given in eq.5 for the two group
data case or the expression given in eq.8 for the one group
data case. For the rest of this section, depending on data
type to be integrated, yj and sj will designate either the
observed effect size given eq.4 and its variance given in
eq.5 or the observed standardized score given in eq.6 and
its variance given in eq.8.
Following Choi et al. [15] if τ2 = 0 in eq.9, then a fixed
effect model (FEM) is used, otherwise a random effect
model (REM) is used. To asses whether FEM or REM is
most appropriate the hypothesis H0 : τ2 = 0 is tested using
the Cochran Q statistics given in eq.10
where wj =   and   is the weighted least square esti-
mator that ignores between-study variability as given in
eq.11
Under the null hypothesis that τ2 = 0, the statistics Q fol-
lows a   distribution where l  designates the total
number of experiments.
If the null hypothesis of τ2  = 0 is rejected, then the
between study variability is estimated using eq.12
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In the case of random effect model (REM)   in eq.11
is now expressed as
where  . The variance of   is given
in eq.14
the z score statistic under REM can then be calculated as
shown in eq.15
In order to estimate the statistical significance of inte-
grated results a permutation-based method developed by
Tusher et al. [35] was used. In our model the permutation
method used for estimating the false discovery rate (FDR)
depends on the type of class labels provided. For the sin-
gle class labels the permutation method is based on the
paired  t-statistic while for the two class label case the
Welch t-statistic is used.
Within each dataset j = 1, 2,...l containing k = 1, 2,..., p
genes, for each permutation b = 1, 2,..B, randomized data
 and   were generated and overall mean 
and variance (see eq.15) were estimated to generate ran-
dom   scores. The zk scores were then ordered (z1 ≤ ...
≤  zp) together with random   scores
 and FDR was estimated using the
expression in eq.16
where zth is the threshold on the z score statistic [15] (see
eq.15), and where I() equals 1 if the condition in paren-
thesis is true, and 0 otherwise.
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